Abnormalities in insulin secretion in type 2 diabetes mellitus

Area of Science:

• Endocrinology
• Metabolic Diseases
• Molecular Biology

Background:

• Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by impaired glucose regulation.
• Key pathophysiological features include reduced peripheral glucose uptake and increased hepatic glucose production.
• Dysfunctional insulin secretion and reduced insulin sensitivity are central to T2DM development.

Purpose of the Study:

• To elucidate the multifactorial nature of T2DM.
• To detail the specific defects in insulin secretion.
• To explain the interplay between insulin secretory defects and insulin resistance.

Main Methods:

• The study is a review of existing literature on T2DM pathophysiology.
• Analysis of beta-cell function, insulin secretion dynamics, and insulin resistance mechanisms.
• Examination of factors contributing to beta-cell failure, including genetic predisposition, glucotoxicity, lipotoxicity, and oxidative stress.

Main Results:

• Multiple defects in insulin secretion are identified, including loss of pulsatility, impaired early-phase secretion, decreased basal and stimulated insulin levels, and progressive decline in secretory capacity.
• Beta-cell dysfunction is genetically determined and manifests early.
• In genetically predisposed individuals, beta-cell failure to compensate for insulin resistance leads to hyperglycemia and overt diabetes.
• Chronic hyperglycemia results in further beta-cell failure due to glucotoxicity, lipotoxicity, and oxidative stress.
• Post-mortem studies reveal reduced beta-cell mass and increased apoptosis in T2DM patients.

Conclusions:

• T2DM results from a complex interplay of genetic predisposition, insulin resistance, and progressive beta-cell dysfunction.
• Beta-cell failure, characterized by secretory defects and reduced mass, is a critical determinant of disease progression.
• Understanding these mechanisms is crucial for developing effective T2DM therapies.